Compare Orchid Chemicals with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ALEMBIC PHARMA - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD ALEMBIC PHARMA ORCHID PHARMA LTD/
ALEMBIC PHARMA
 
P/E (TTM) x -0.5 16.2 - View Chart
P/BV x 0.1 3.7 3.2% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 ORCHID PHARMA LTD   ALEMBIC PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ALEMBIC PHARMA
Mar-19
ORCHID PHARMA LTD/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs194664 29.2%   
Low Rs35412 8.5%   
Sales per share (Unadj.) Rs276.5208.7 132.5%  
Earnings per share (Unadj.) Rs-79.231.0 -255.5%  
Cash flow per share (Unadj.) Rs-43.537.1 -117.1%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs53.9144.2 37.4%  
Shares outstanding (eoy) m70.45188.52 37.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.6 16.1%   
Avg P/E ratio x-1.417.4 -8.3%  
P/CF ratio (eoy) x-2.614.5 -18.2%  
Price / Book Value ratio x2.13.7 56.9%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m8,067101,461 8.0%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5277,467 33.8%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,47739,347 49.5%  
Other income Rs m40794 434.1%   
Total revenues Rs m19,88439,441 50.4%   
Gross profit Rs m1,1038,736 12.6%  
Depreciation Rs m2,5191,152 218.6%   
Interest Rs m5,227184 2,839.1%   
Profit before tax Rs m-6,2367,493 -83.2%   
Minority Interest Rs m2011 182.4%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1251,568 -8.0%   
Profit after tax Rs m-5,5805,844 -95.5%  
Gross profit margin %5.722.2 25.5%  
Effective tax rate %2.020.9 9.6%   
Net profit margin %-28.714.9 -192.9%  
BALANCE SHEET DATA
Current assets Rs m11,01419,577 56.3%   
Current liabilities Rs m32,06014,896 215.2%   
Net working cap to sales %-108.111.9 -908.3%  
Current ratio x0.31.3 26.1%  
Inventory Days Days9590 105.7%  
Debtors Days Days3445 74.0%  
Net fixed assets Rs m29,44027,097 108.6%   
Share capital Rs m705377 186.9%   
"Free" reserves Rs m2,04326,811 7.6%   
Net worth Rs m3,80027,188 14.0%   
Long term debt Rs m9,0184,993 180.6%   
Total assets Rs m46,51047,778 97.3%  
Interest coverage x-0.241.7 -0.5%   
Debt to equity ratio x2.40.2 1,292.3%  
Sales to assets ratio x0.40.8 50.8%   
Return on assets %-0.812.6 -6.0%  
Return on equity %-146.921.5 -683.2%  
Return on capital %-3.723.6 -15.8%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,51319,453 38.6%   
Fx outflow Rs m5,6496,065 93.1%   
Net fx Rs m1,86513,388 13.9%   
CASH FLOW
From Operations Rs m1,6828,120 20.7%  
From Investments Rs m-9,860-7,556 130.5%  
From Financial Activity Rs m6,644590 1,125.3%  
Net Cashflow Rs m-1,5351,153 -133.1%  

Share Holding

Indian Promoters % 32.3 74.1 43.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 2.9 158.6%  
FIIs % 3.3 9.1 36.3%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 13.9 397.8%  
Shareholders   84,811 49,328 171.9%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   SUN PHARMA  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  DR. REDDYS LAB  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Climbs 200 Points; Yes Bank and Reliance Industries Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. All sectoral indices are trading in green with stocks in the capital goods sector.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS